Effect of Oculomotor Therapy in Individuals With Convergence Insufficiency
- Sponsor
- University of Nove de Julho
- Study ID
- NCT07036263
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 60 Years
- Healthy Volunteers
- Not accepted
Interventions
- Oculomotor therapy — OTHEROculomotor therapy will follow and adapt the protocol for treating convergence insufficiency (CI). Procedures will be organized progressively, from easiest to most difficult. Gross convergence techniques: (1) Brock String: A 1.5-2 m cord with colored beads; the patient focuses on each bead to train binocular fusion, observing the "X" shape of the cord. (2) Barillé Chart: A card with paired images for each eye; the patient merges the images into one using convergence and sensory fusion. Accommodative techniques: (1) Eccentric Circles: Printed circles with eccentric marks; viewed through filters to train motor and sensory fusion by aligning them into a single 3D image. (2) Opaque Lifesaver Cards: Cards with figures on an opaque background, used with red-green filters to stimulate convergence and fixation by reducing peripheral stimuli and enhancing visual attention.
- No Treatment Added — OTHERParticipants in the control group will not receive any type of treatment for a period of five weeks. After this period, they will be re-evaluated
Study Details
The aim of this study is to investigate the effect of oculomotor therapy in individuals with ocular convergence insufficiency.
Key Dates
- Start date
- Aug 1, 2025
- Status verified
- Jun 2025
- Primary completion
- Nov 30, 2025
- Completion
- Dec 30, 2025
Study Design
- Enrollment
- 70 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Experimental Group (EG)This group will receive treatment with oculomotor therapy
- Other: Control group (CG)This group will not receive any type of treatment
Primary Outcome Measure
General mobility [ Time Frame: 3 months ]
Related Studies
- Non-invasive Brain Stimulation for Treating Symptomatic Convergence InsufficiencyRecruiting · Midwestern University · Downers Grove, Illinois
- Eye Recovery Automation for Post Injury Dysfunction (iRAPID)Recruiting · New Jersey Institute of Technology · Albuquerque, New Mexico
- Home-based Vision TherapyPHASE1 · Recruiting · VA Office of Research and Development · Cleveland, Ohio